Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma
Occult hepatitis B (OBI) is caused by a persistent low-level replication of HBV. Like overt HBV infection, OBI can be associated with the integration of HBV sequences into the host genome and has a substantial clinical relevance for patients who are severely immunosuppressed for long durations. We p...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2012/803298 |
id |
doaj-85aead0d5334423e8277242dd4a8b07c |
---|---|
record_format |
Article |
spelling |
doaj-85aead0d5334423e8277242dd4a8b07c2020-11-24T20:40:43ZengHindawi LimitedCase Reports in Hematology2090-65602090-65792012-01-01201210.1155/2012/803298803298Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell LymphomaVincenzo Pitini0Massimo Rizzo1Carmela Arrigo2Patrizia Mondello3Giuseppe Altavilla4Department of Medical Oncology (Pad. H 5° Piano), University of Messina, Via Consolare Valeria Road 98125 Messina, ItalyDepartment of Medical Oncology (Pad. H 5° Piano), University of Messina, Via Consolare Valeria Road 98125 Messina, ItalyDepartment of Medical Oncology (Pad. H 5° Piano), University of Messina, Via Consolare Valeria Road 98125 Messina, ItalyDepartment of Medical Oncology (Pad. H 5° Piano), University of Messina, Via Consolare Valeria Road 98125 Messina, ItalyDepartment of Medical Oncology (Pad. H 5° Piano), University of Messina, Via Consolare Valeria Road 98125 Messina, ItalyOccult hepatitis B (OBI) is caused by a persistent low-level replication of HBV. Like overt HBV infection, OBI can be associated with the integration of HBV sequences into the host genome and has a substantial clinical relevance for patients who are severely immunosuppressed for long durations. We present the case of a patient with a diffuse large B-cell non-Hodgkin lymphoma and OBI who developed a hepatocellular carcinoma with a fulminant clinical course following the administration of rituximab plus CHOP.http://dx.doi.org/10.1155/2012/803298 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vincenzo Pitini Massimo Rizzo Carmela Arrigo Patrizia Mondello Giuseppe Altavilla |
spellingShingle |
Vincenzo Pitini Massimo Rizzo Carmela Arrigo Patrizia Mondello Giuseppe Altavilla Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma Case Reports in Hematology |
author_facet |
Vincenzo Pitini Massimo Rizzo Carmela Arrigo Patrizia Mondello Giuseppe Altavilla |
author_sort |
Vincenzo Pitini |
title |
Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma |
title_short |
Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma |
title_full |
Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma |
title_fullStr |
Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma |
title_full_unstemmed |
Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma |
title_sort |
fatal hepatocellular carcinoma in a patient with occult hepatitis b virus infection following the administration of r-chop for diffuse large b-cell lymphoma |
publisher |
Hindawi Limited |
series |
Case Reports in Hematology |
issn |
2090-6560 2090-6579 |
publishDate |
2012-01-01 |
description |
Occult hepatitis B (OBI) is caused by a persistent low-level replication of HBV. Like overt HBV infection, OBI can be associated with the integration of HBV sequences into the host genome and has a substantial clinical relevance for patients who are severely immunosuppressed for long durations. We present the case of a patient with a diffuse large B-cell non-Hodgkin lymphoma and OBI who developed a hepatocellular carcinoma with a fulminant clinical course following the administration of rituximab plus CHOP. |
url |
http://dx.doi.org/10.1155/2012/803298 |
work_keys_str_mv |
AT vincenzopitini fatalhepatocellularcarcinomainapatientwithocculthepatitisbvirusinfectionfollowingtheadministrationofrchopfordiffuselargebcelllymphoma AT massimorizzo fatalhepatocellularcarcinomainapatientwithocculthepatitisbvirusinfectionfollowingtheadministrationofrchopfordiffuselargebcelllymphoma AT carmelaarrigo fatalhepatocellularcarcinomainapatientwithocculthepatitisbvirusinfectionfollowingtheadministrationofrchopfordiffuselargebcelllymphoma AT patriziamondello fatalhepatocellularcarcinomainapatientwithocculthepatitisbvirusinfectionfollowingtheadministrationofrchopfordiffuselargebcelllymphoma AT giuseppealtavilla fatalhepatocellularcarcinomainapatientwithocculthepatitisbvirusinfectionfollowingtheadministrationofrchopfordiffuselargebcelllymphoma |
_version_ |
1716825867456348160 |